Although non-Hispanic white women have an increased risk of developing breast cancer, the disease-specific survival is lower for African American and Hispanic women. Little is known about disparities in follow-up after an abnormal mammogram. The goal of this study was to investigate potential disparities in follow-up after an abnormal mammogram.
Methods:
A retrospective cohort study of 6722 women with an abnormal mammogram and documented follow-up from January 2000 through December 2002 was performed at an academic medical center in New York City. The outcome was the number of days between the abnormal mammogram and follow-up imaging or biopsy. Cox proportional hazards models were used to assess the effect of race/ethnicity and other potential covariates.
Results:
The median number of days to diagnostic follow-up after an abnormal mammogram was greater for African American (20 days) and Hispanic (21 days) women compared with non-Hispanic white (14 days) women (p < 0.001). Racial/ethnic disparities remained significant in a multivariable model controlling for age, Breast Imaging Reporting and Data System (BIRADS) category, insurance status, provider practice location, and median household income.
Conclusions:
After an abnormal mammogram, African American and Hispanic women had longer times to diagnostic follow-up compared with non-Hispanic white women. Future efforts will focus on identifying the barriers to follow-up so that effective interventions may be implemented.
Get full access to this article
View all access options for this article.
References
1.
Surveillance, Epidemiology, End Results (SEER)2002Novemberwww.cancer.org
2.
BradleyCJ, GivenCW, RobertsC. Disparities in cancer diagnosis and survival. Cancer, 2001; 91:178–188.
3.
LiCI, MaloneKE, DalingJR. Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med, 2003; 163:49–56.
4.
FreemanHP, ReubenSH. Voices of a broken system. Real problems, real people. Presidents Cancer Panel Report of the chairman, 2000–2001. Bethesda, MD: National Cancer Program National Cancer Institute, 2001.
5.
ZapkaJG, TaplinSH, SolbergLI, ManosMM. A framework for improving the quality of cancer care: The case of breast and cervical cancer screening. Cancer Epidemiol Biomarkers Prev, 2003; 12:4–13.
6.
WardE, JemalA, CokkinidesVet al.Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin, 2004; 54:78–93.
7.
LiFP, DigianniLM. Reducing the unequal burden of cancer. Cancer Epidemiol Biomarkers Prev, 2003; 12:230s–231s.
8.
KaplanCP, EisenbergM, EricksonPI, CraneLA, DuffeyS. Barriers to breast abnormality follow-up: Minority, low-income patients' and their providers' view. Ethnicity Dis, 2005; 15:720–726.
9.
WeinmannS, TaplinSH, GilbertJet al.Characteristics of women refusing follow-up for tests or symptoms suggestive of breast cancer. Natl Cancer Inst, 2005; 35:33–38.
10.
FreemanHP. Commentary on the meaning of race in science and society. Cancer Epidemiol Biomarkers Prev, 2003; 12,Suppl:232s–236s.
11.
GrauAM, AtaA, FosterLet al.Effect of race on long-term survival of breast cancer patients: Transinstitutional analysis from an inner city hospital and university medical center. Am Surg, 2005; 71:164–70.
12.
ChenF, TrapidoEJ, DavisK. Differences in stage at presentation of breast and gynecologic cancers among whites, blacks, and Hispanics. Cancer, 1994; 73:2838–2842.
13.
DavidsonPL, BastaniR, NakazonoTT, CarreonDC. Role of community risk factors and resources on breast carcinoma stage at diagnosis. Cancer, 2005; 103:922–930.
14.
LanninDR, MathewsHR, MitchellJ, SwansonMS, SwansonFH, EdwardsMS. Influence of socioeconomic and cultural factors on racial differences in late-stage presentaion of breast cancer. JAMA, 1998; 279:1801–1807.
15.
VelanovichV, MarianneUY, BawleUet al.Racial differences in the presentation and surgical management of breast cancer. Surgery, 1999; 125:372–379.
16.
LanzPM, MujahidM, SchwartzKet al.The influence of race, ethnicity, and individual socioeconomic factors on breast cancer stage at diagnosis. Am J Public Health, 2006; 96:2173–2178.
17.
SassiF, LuftH, GuadagnoliE. Reducing racial/ethnic disparities in female breast cancer: Screening rates and stage at diagnosis. Am J Public Health, 2006; 96:2165–2172.
18.
RichardsMA, WestcombeAM, LoveSB, LittlejohnsP, RamirezAJ. Influence of delay on survival in patients with breast cancer: A systematic review. Lancet, 1999; 353:1119–1126.
19.
DennisCR, GardnerB, LimB. Analysis or survival and recurrence vs. patient and doctor delay in treatment of breast cancer. Cancer, 1975; 35:714–720.
20.
GwynK, BondyM, CohenDSet al.Racial differences in diagnosis, treatment, and clinical delays in a population-based study of patients with newly diagnosed breast carcinoma. Cancer, 2004; 100:1595–1604.
21.
TropmanSE, RickettsTC, PaskettE, HatzellTA, CooperMR, AldrichT. Rural breast cancer treatment: Evidence from the Reaching Communities for Cancer Care (REACH) project. Breast Cancer Res Treat, 1999; 56:59–66.
22.
ChuKC, LamarCA, FreemanHP. Racial disparities in breast carcinoma survival rates: Separating factors that affect diagnosis from factors that affect treatment. Cancer, 2003; 97:2853–2860.
23.
HarlanLC, AbramsJ, WarrenJL, CleggL, StevensJ, Ballard-BarbashR. Adjuvant therapy for breast cancer: Practice patterns of community physicians. J Clin Oncol, 2002; 20:1809–1817.
24.
HershmanD, McBrideR, JacobsonJSet al.Racial disparities in treatment and survival among women with early-stage breast cancer. J Clin Oncol, 2005; 23:6639–6646.
25.
JoslynS, WestM. Racial differences in breast carcinoma survival. Cancer, 2000; 88:114–123.
26.
ElledgeRA, ClarkGM, ChamnessGC, OsborneCK. Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States. J Natl Cancer Inst, 1994; 86:705–712.
27.
JonesBA, KaslSV, HoweCLet al.African-American/white differences in breast carcinoma: p53 alterations and other tumor characteristics. Cancer, 2004; 101:1293–1301.
28.
CaplanLS, MayDS, RichardsonLC. Time to diagnosis and treatment of breast cancer: Results from the National Breast and Cervical Cancer Early Detection Program, 1991–1995. Am J Public Health, 2000; 90:130–134.
29.
ChangSW, KerlikauskeK, Napoles-SpringerA, PosnerS, SicklesEA, Perez-StableE. Racial differences in timeliness of follow-up after abnormal screening mammography. Cancer, 1996; 78:1395–1402.
30.
JonesBA, DaileyA, CalvocoessiLet al.Inadequate follow-up of abnormal screening mammograms: Findings from the Race Differences in Screening Mammography Process Study (United States)Cancer Causes Control, 2005; 16:809–821.
31.
KernerJ, YedidiaM, PadgettDet al.Realizing the promise of breast cancer screening: Clinical follow-up after abnormal screening among black women. Prev Med, 2003; 37:92–101.
32.
FerranteJM, RoviS, DasK, KimS. Family physicians expedite diagnosis of breast disease in urban minority women. J Am Board Fam Med, 2007; 20:52–59.
33.
U.S. Census Bureau. “American Fast Finder”www.factfinder.census.gov. 2007June.
34.
KerlikowskeK. Timeliness of follow-up after abnormal screening mammography. Breast Cancer Res Treat, 1996; 41:53–64.
35.
ElmoreJG, NakanoCY, LindenHM, ReischLM, AyanianJZ, LarsonEB. Racial inequities in the timing of breast cancer detection, diagnosis, and initiation of treatment. Med Care, 2005; 43:141–148.
36.
LermanC, TrockB, RimerBK, BoyceA, JepsonC, EngstromPF. Psychological and behavioral implications of abnormal mammograms. Ann Intern Med, 1991; 114:657–661.
37.
Ashing-GiwaKT, PadillaG, TejeroJet al.Understanding the breast cancer experience of women: A qualitative study of African American, Asian American, Latina and Caucasian cancer survivors. Psychooncology, 2004; 13:408–428.
38.
CoyneC, HohmanK, LevinsonA. Reaching special populations with breast and cervical cancer public education. J Cancer Educ, 1992; 7:293–303.
39.
JonesBA, ReamsK, CalvocoressiL, DaileyA, KasiSV, ListonNM. Adequacy of communicating results from screening mammograms to African American and white women. Am J Public Health, 2007; 97:531–538.
40.
KarlinerKS, KaplanCP, JuarbeT, PasickR, Perez-StableEJ. Poor patient comprehension of abnormal mammography results. J Gen Intern Med, 2005; 20:432–437.
41.
KaplanCP, CraneL, StewartS, Juarez-ReyesM. Factors affecting follow-up among low-income women with breast abnormalities. J Womens Health, 2004; 13:195–206.
42.
ArnsbergerP, FoxP, RyderP, NusseyB, ZhangX, Otero-SabogolR. Timely follow-up among multicultural women with abnormal mammograms. Am J Health Behav, 2006; 30:51–61.
43.
Hoffman-GoetzL, FriedmanDB. Disparities in the coverage of cancer informaton in ethnic minority and mainstream mass print media. Ethn Dis, 2005; 15:332–340.
44.
GodfreyJ. Toward optimal health: Judy Ann Bigby, M.D., discusses the need for cultural competence in the healthcare of women. J Womens Health, 2006; 15:480–483.
45.
AzaizaF, CohenM. Health beliefs and rates of breast cancer screening among Arab women. J Womens Health, 2006; 15:520–529.
46.
ShiraziM, ChampeauD, TalebiA. Predictors of breast cancer screening among immigrant Iranian women in California. J Womens Health, 2006; 15:485–506.
47.
KreuterMW, Sugg-SkinnerC, HoltCLet al.Cultural tailoring for mammography and fruit and vegetable intake among low-income African-American women in urban public health centers. Prev Med, 2005; 41:53–62.
48.
CorkeryE, PalmerC, FoleyME, SchecterCB, RisherL, RomanSH. Effect of a bicultural community health worker on completion of diabetes education in a Hispanic popultion. Diabetes Care, 1997; 20:254–257.
49.
WeberBE, ReillyBM. Enhancing mammography use in the inner city. A randomized trial of intensive case management. Arch Intern Med, 1997; 157:2345–2349.
50.
FernandezME, DeBorM, CandreiaMJ, WagnerAK, StewartKR. Evaluation of ENCOREplus. A community-based breast and cervical cancer screening program. Am J Prev Med, 1999; 16,3 Suppl:35–49.
51.
EllK, VourlekisB, LeePJ, XieB. Patient navigation and case management following an abnormal mammogram: A randomized clinical trial. Prev Med, 2007; 44:26–33.
52.
BattagliaTA, RoloffK, PosnerMA, FreundKM. Improving follow-up to abnormal breast cancer screening in an urban population; A patient navigation intervention. Cancer, 2007; 109,2 Suppl:359–367.
53.
RamirezRR, de la CruzGP. The Hispanic population in the United States: March 2002. Current population report. Washington, DC: U.S. Census Bureau, 2002; 20–545.
54.
ArdaySL, ArdayDR, MonroeS, ZhangJ. HCFA's racial and ethnic data: Current accuracy and recent improvements. Health Care Financing Rev, 2000; 21:107–116.
55.
OlfsonM, Lewis-FernandezR, WeissmanMMet al.Psychotic symptoms in an urban general medicine practice. Am J Psychiatry, 2002; 159:1412–1419.
56.
OlfsonM, SheaS, FederAet al.Prevalence of anxiety, depression, and substance use disorders in an urban general medicine practice. Arch Fam Med, 2000; 9:876–883.
